About: Long-term cervical cancer prevention strategies across the globe

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Long-term cervical cancer prevention strategies across the globe Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 02 February 2010

Attributes	Values
rdf:type	Item
description	videnskabelig artikel (da) article científic (ca) articolo scientifico (it) artigo científico (pt) bilimsel makale (tr) vedecký článok (sk) vetenskaplig artikel (sv) vědecký článek (cs) wetenschappelijk artikel (nl) wissenschaftlicher Artikel (de) научни чланак (sr) bài báo khoa học (vi) article scientifique (fr) artículu científicu espublizáu en 2010 (ast) наукова стаття, опублікована в лютому 2010 (uk) scientific article published on 02 February 2010 (en) مقالة علمية نشرت في 02 فبراير 2010 (ar)
publication date	wds:Q37686830-085B4A2E-76BE-4C11-ADF0-A5911EDE6355
publication date	2010-02-02 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q37686830-39ECCFFD-BE07-4FA4-9200-B0031B93223A
language of work or name	English
cites work	wds:Q37686830-007D4EF2-7616-43BD-802F-1CAEEC095141 wds:Q37686830-13FFED3A-788F-4612-9124-A3488595719F wds:Q37686830-18892D11-08A5-49F0-9387-46C092FFA318 wds:Q37686830-2A1F6A88-B7A0-4466-A263-D573391D9919 wds:Q37686830-2CF713A7-1990-43A0-BF4F-15A745865D0D wds:Q37686830-3A04E83F-8AD9-4DAD-9979-152CC6878B30 wds:Q37686830-4CD1CBF7-773F-46CA-A0FC-A160247CEB33 wds:Q37686830-566C7771-761E-4DF9-A88A-22B570EDCE5A wds:Q37686830-5FAC9A5A-7E10-4E47-BC04-955D315A46E4 wds:Q37686830-63812A68-6DDB-48E6-AECB-563283F89173 wds:Q37686830-64DE5B3C-3ADA-4034-A795-F89884DAE04E wds:Q37686830-69484BD4-384C-48E9-9E5C-3DB443616505 wds:Q37686830-857C223E-542E-462F-8B41-1D8060D4DFE1 wds:Q37686830-945C7B47-DCED-4868-A30A-D7F42DE2D581 wds:Q37686830-ABC195B9-B243-4AF9-974C-A16E431CCD4E wds:Q37686830-ABF56CCA-9E30-4E2C-97D9-56466FF7BF8D wds:Q37686830-AC09608E-35F2-4642-B95E-EE3EBA948443 wds:Q37686830-D7A7768E-1549-4658-93B2-E382A532E4B0 wds:Q37686830-DB2BA0EC-8026-4584-A252-F83AE16D2386 wds:Q37686830-DCF450A5-1991-4908-A827-7CCF7C74C57A wds:Q37686830-E38959BD-AC96-4D91-9C93-C576E3751703 wds:Q37686830-E75E56CE-0918-4713-9122-30B07B49C066 wds:Q37686830-E887B196-41C5-4D19-810A-AA25419C137C wds:Q37686830-EE89AF4A-66EC-4B09-AA57-BE7FA38EB41E wds:Q37686830-F0D5EBED-4FA8-48F7-B23A-6D48D1ED5793 wds:Q37686830-F92F633F-02F6-4F60-A5C5-EBBC18376A72
cites work	Sustained efficacy and immunogenicity of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine: analysis of a randomised placebo-controlled trial up to 6.4 years Overview of the European and North American studies on HPV testing in primary cervical cancer screening Description of the national situation of cervical cancer screening in the member states of the European Union Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer. Five-year experience of human papillomavirus DNA and Papanicolaou test cotesting Human papillomavirus testing by self-sampling: assessment of accuracy in an unsupervised clinical setting Interim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screening Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries Classification of papillomaviruses High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions Effect of prophylactic human papillomavirus L1 virus-like-particle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ: a combined analysis of four randomised clinical trials Direct visual inspection for cervical cancer screening: an analysis of factors influencing test performance Age-specific evaluation of primary human papillomavirus screening vs conventional cytology in a randomized setting. Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three randomised clinical trials A review of prophylactic human papillomavirus vaccines: recommendations and monitoring in the US. Long-term follow-up of cervical abnormalities among women screened by HPV testing and cytology-Results from the Hammersmith study. Results at recruitment from a randomized controlled trial comparing human papillomavirus testing alone with conventional cytology as the primary cervical cancer screening test. Evaluation of alternative methods of cervical cancer screening for resource-poor settings The impact of new technologies in cervical cancer screening: results of the recruitment phase of a large randomised controlled trial from a public health perspective Evaluation of visual inspection with acetic acid (VIA), Lugol's iodine (VILI), cervical cytology and HPV testing as cervical screening tools in Latin America. This report refers to partial results from the LAMS (Latin AMerican Screening) study. Risk of high-grade cervical intra-epithelial neoplasia based on cytology and high-risk HPV testing at baseline and at 6-months Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study Cervical cancer screening following prophylactic human papillomavirus vaccination
author name string	wds:Q37686830-FD4B70FB-2BE4-47B3-876D-1650B1BF8C98
author name string	Jack Cuzick
rdfs:label	Long-term cervical cancer prevention strategies across the globe (en) Long-term cervical cancer prevention strategies across the globe (nl) Long-term cervical cancer prevention strategies across the globe (ast)
skos:prefLabel	Long-term cervical cancer prevention strategies across the globe (en) Long-term cervical cancer prevention strategies across the globe (nl) Long-term cervical cancer prevention strategies across the globe (ast)
name	Long-term cervical cancer prevention strategies across the globe (en) Long-term cervical cancer prevention strategies across the globe (nl) Long-term cervical cancer prevention strategies across the globe (ast)
title	wds:Q37686830-C17CE0E7-F706-4B92-A243-0BDBD9DA5F68
title	Long-term cervical cancer prevention strategies across the globe (en)
page(s)	wds:Q37686830-A5943161-F241-4077-9C63-7AFD61009E57
page(s)	S11-4
instance of	wds:Q37686830-1B6638C3-374E-42E8-82E9-70C87C156DD5 wds:Q37686830-e16e6f59-51f2-4661-ab62-561ddf1d0f79
instance of	review article scholarly article
main subject	wds:Q37686830-5F58AB8F-5822-4538-B9AD-27A2C8A361EB
main subject	cervix uterine cancer
PubMed ID	wds:Q37686830-153FD1F6-EC7F-4181-BF17-9B44EB2CD9E0
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/20129652
PubMed ID	20129652
published in	wds:Q37686830-EB490CEA-8F6E-46F3-8BA4-69633F7C6B78
published in	Gynecologic Oncology

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 196 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software